Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile. | Rheumatology (Oxford) | 2025 | 38781517 | PubTator, text mining | PubMed |
| A targetable developmental program co-regulates angiogenesis and immune evasion. | bioRxiv | 2024 | 39764043 | PubTator, text mining | PubMed |
Functional and phenotypic changes in natural killer cells expressing immune checkpoint receptors PD-1, CTLA-4, LAG-3, and TIGIT in non-small cell lung cancer: the comparative analysis of tumor microenvironment, peripheral venous blood, and tumor-draining veins. | Immunol Res | 2024 | 39695033 | PubTator, text mining | PubMed |
| Comparative study of the three-dimensional genomes of granulosa cells in germinal vesicle and metaphase II follicles. | Front Genet | 2024 | 39634272 | PubTator, text mining | PubMed |
| T-cell and Soluble Co-inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome. | Open Forum Infect Dis | 2024 | 39564149 | PubTator, text mining | PubMed |
| Efficacy of subcutaneous specific immunotherapy for allergic rhinitis combined with asthma: a retrospective analysis. | Am J Transl Res | 2024 | 39544754 | PubTator, text mining | PubMed |
| Immune checkpoint molecules performance in ANCA vasculitis. | RMD Open | 2024 | 39537557 | PubTator, text mining | PubMed |
| Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality. | iScience | 2024 | 39507250 | PubTator, text mining | PubMed |
| Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease. | J Neuroinflammation | 2024 | 39427168 | PubTator, text mining | PubMed |
| Letter: Muddle of serum sPD-1 and sPD-L1 levels and association with HBsAg clearance in HBeAg-negative CHB patients on IFN therapy. | Aliment Pharmacol Ther | 2024 | 39415731 | PubTator, text mining | PubMed |
| Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes. | Biomark Res | 2024 | 39379980 | PubTator, text mining | PubMed |
| Relaxed selection in evolution of genes regulating limb development gives clue to variation in forelimb morphology of cetaceans and other mammals. | Proc Biol Sci | 2024 | 39378996 | PubTator, text mining | PubMed |
| A Systematic Review on Biomarkers: Are There Reliable Molecular Biomarkers in Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease? | Cureus | 2024 | 39247043 | PubTator, text mining | PubMed |
| Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs. | Int Immunopharmacol | 2024 | 39168022 | PubTator, text mining | PubMed |
| Exploring the relationship between anal fistula and colorectal cancer based on Mendelian randomization and bioinformatics. | J Cell Mol Med | 2024 | 39120548 | PubTator, text mining | PubMed |
| Prognostic significance of soluble PD-L1 in prostate cancer. | Front Immunol | 2024 | 39055716 | PubTator, text mining | PubMed |
| Evaluation of soluble co-inhibitors and co-stimulators levels of the immune response in gastric cancer. | J Surg Oncol | 2024 | 38946193 | PubTator, text mining | PubMed |
| Soluble form of immune checkpoints in autoimmune diseases. | J Autoimmun | 2024 | 38943864 | PubTator, text mining | PubMed |
Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and osteogenesis. | J Ovarian Res | 2024 | 38907278 | PubTator, text mining | PubMed |
| A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects. | Int Immunopharmacol | 2024 | 38852522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=6